Lorena Alba-Castellón

5PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 04, 2025
A Targeted Nanotoxin Inhibits Colorectal Cancer Growth Through Local Tumor Pyroptosis and Eosinophil Infiltration and Degranulation.

Luis Miguel Carrasco-Díaz, Alberto Gallardo, Eric Voltà-Durán

|Jun 19, 2024
CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas.

Anna C Virgili, Juliana Salazar, Alberto Gallardo

|Jan 08, 2023
Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models.

Esperanza Medina-Gutiérrez, Annabel García-León, Alberto Gallardo

|Jul 27, 2022
Novel Endometrial Cancer Models Using Sensitive Metastasis Tracing for CXCR4-Targeted Therapy in Advanced Disease.

Esperanza Medina-Gutiérrez, María Virtudes Céspedes, Alberto Gallardo

|Apr 23, 2022
A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model.

Elisa Rioja-Blanco, Alberto Gallardo, Irene Arroyo-Solera

Pageof 1

Frequent Collaborators

5 joint publications

Ramon Mangues

3 joint publications

Antonio Villaverde

3 joint publications

Ugutz Unzueta

2 joint publications

Elisa Rioja-Blanco